![]() |
市场调查报告书
商品编码
1886956
便携式超音波设备市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察,以及2024-2032年预测Compact Ultrasound Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受全球慢性病发病率上升、人口老化、技术进步以及即时诊断技术广泛应用等因素的推动,全球便携式超音波设备市场持续快速成长。根据最新产业数据,预计2024年全球便携式超音波设备市场规模将达26.5亿美元,2025年将达29.7亿美元。预计到2032年,该市场将进一步成长至64亿美元,2025年至2032年的复合年增长率将达到11.6%。对高度便携、精准、高效的成像设备日益增长的需求,是推动市场强劲成长的主要动力。
市场概览
紧凑型超音波设备是传统桌上型超音波系统的小型便携式版本。其轻巧便携的设计使其能够在医院、诊所、门诊机构和偏远地区提供高品质的影像。它们能够在护理点提供即时影像,从而推动了全球需求。预计到2024年,北美将占市场主导地位,市占率达35.84%,市场规模将达到9.5亿美元,主要得益于先进的医疗基础设施和慢性病的高发生率。
领先的公司——皇家飞利浦公司、富士胶片株式会社、佳能医疗系统株式会社、通用电气医疗集团和柯尼卡美能达株式会社——正透过推出新产品、开发整合人工智慧的设备以及拓展新的临床应用领域不断进行创新。
市场驱动因素
推动该市场发展的关键因素是全球慢性疾病的增加,例如心血管疾病、肾臟病、癌症和代谢性疾病,这些疾病需要透过非侵入性影像进行频繁监测。例如,美国国立卫生研究院 (NIH) 于 2024 年 9 月报告称,截至 2023 年,美国将有超过 80.8 万人患有终末期肾病。美国国家生物技术资讯中心 (NCBI) 也估计,2025 年美国将新增约 200 万例癌症病例。此外,世界卫生组织 (WHO) 于 2025 年 2 月预测,60 岁及以上人口将从 2023 年的 11 亿增加到 2030 年的 14 亿,这将推动对诊断解决方案的需求。
超音波技术安全、经济高效且易于操作,因此在急诊医学、心臟病学、妇科、肾臟病学、泌尿科和家庭医疗保健等领域广泛应用。这种转变正在推动全球对小型便携式设备的需求不断增长。
市场限制因子
产品召回、监管警告以及熟练超音波技师短缺在一定程度上阻碍了市场成长。频繁的召回事件,例如飞利浦因发烧问题于2024年3月召回其5000系列紧凑型超音波设备(属于二级召回),以及Spark公司在2021年召回其设备,正在影响消费者信心并阻碍其广泛应用。此外,人才短缺也是一个挑战。英国2024年临床放射科医师调查发现,临床放射科医师缺口达30%,预计2028年将达40%。
市场机会
治疗性超音波应用(神经调控、伤口护理、标靶药物传递、癌症治疗等)的进步为市场扩张带来了巨大的机会。例如,Insightec公司的Exablate 4000平台于2021年获得巴西国家卫生监督局(ANVISA)的批准,该平台利用磁振造影引导聚焦超音波技术,对特发性震颤和帕金森氏症进行非侵入性治疗。
合作关係也为成长指明了方向。一个值得注意的例子是Buck Baits LLC和Kuhl Beans Roasting Company于2025年达成的合作,这将增强供应链的稳定性,并展现影像生态系统内更广泛的合作。
市场趋势
推动市场成长的关键趋势之一是将人工智慧 (AI) 整合到小型超音波系统中。 AI 演算法可以提高影像清晰度、实现测量自动化、提升即时解读的准确性并降低对操作者的依赖性。 2025 年 3 月,飞利浦发布了 5500CV,这是一款支援 AI 的小型超音波系统,凸显了业界向更智慧、更有效率的影像解决方案转型的趋势。
製造商也正在开发便携式 3D 和 4D 成像系统,以扩展诊断功能。飞利浦在 2022 年北美放射学会 (RSNA) 上发布的 5000 系列可为心血管、妇产科和床边应用提供先进的 3D 影像。
细分市场洞察
预计在迈瑞 Consona 系列等基于控制台的便携式设备的推出推动下,嵌入式控制台细分市场将在 2024 年引领市场。由于市场对轻巧、现代、触控系统的需求不断增长,因此触控萤幕市场预计将保持稳定成长。
依成像类型划分,3D 成像市场占主导地位,其中支援即时视觉化的 4D 成像市场迅速成长。
依应用领域划分,放射科将在 2024 年占最大占有率,这得益于人工智慧设备的推出,例如 Wipro GE 于 2025 年 3 月推出的 Versana Premier R3。医院诊所仍然是主要终端用户,这主要受住院率上升和超音波在慢性病诊断中应用日益广泛推动。
北美市场领先,欧洲市场保持稳定成长,这得益于 2023 年佳能发布的 Aplio Flex 和 Aplio Go 系统等新产品。亚太地区是成长最快的地区,这主要受慢性病盛行率上升和对早期诊断日益重视的推动。由于策略性医疗保健措施和诊断技术的普及,拉丁美洲、中东和非洲地区的医疗保健事业正在蓬勃发展。
The global compact ultrasound equipment market continues to expand rapidly, supported by the rising global burden of chronic diseases, growing geriatric population, technological advancements, and the widespread adoption of point-of-care diagnostics. According to the latest industry data, the global compact ultrasound equipment market was valued at USD 2.65 billion in 2024, is projected to reach USD 2.97 billion in 2025, and further expand to USD 6.40 billion by 2032, registering an impressive CAGR of 11.6% between 2025 and 2032. The growing need for portable, accurate, and efficient imaging devices is shaping the market's strong upward trajectory.
Market Overview
Compact ultrasound machines are smaller, portable versions of traditional console ultrasound systems, offering high-quality imaging in a lightweight, mobile design suitable for hospitals, clinics, ambulatory care settings, and remote locations. Their ability to deliver real-time imaging at the point of care is driving global demand. In 2024, North America dominated the market with a 35.84% share, generating USD 0.95 billion, owing to its advanced healthcare infrastructure and high prevalence of chronic diseases.
Leading companies-including Koninklijke Philips N.V., FUJIFILM Corporation, CANON MEDICAL SYSTEMS CORPORATION, GE HealthCare, and Konica Minolta, Inc.-continue to innovate with new product launches, AI-integrated devices, and expansion into new clinical applications.
Market Drivers
A critical driver for the market is the increasing global prevalence of chronic illnesses, such as cardiovascular diseases, kidney disorders, cancers, and metabolic diseases-conditions that require frequent diagnostic monitoring using non-invasive imaging. For instance, the NIH reported in September 2024 that over 808,000 people in the U.S. were living with end-stage renal disease in 2023, while the NCBI estimated around 2.0 million new cancer diagnoses in the U.S. for 2025. Additionally, the WHO projected in February 2025 that the global population aged 60+ will rise from 1.1 billion in 2023 to 1.4 billion by 2030, increasing demand for diagnostic solutions.
As ultrasound is safe, cost-effective, and easy to use, its adoption is rising across emergency care, cardiology, gynecology, nephrology, urology, and home-based care environments. This shift supports the growing global preference for compact, mobile devices.
Market Restraints
Market growth is partially hindered by product recalls, regulatory warnings, and shortages of skilled ultrasound technicians. Frequent recalls-such as Philips' Class 2 recall in March 2024 for its 5000 Compact Series due to heating issues, and Sparq device recall in 2021-affect consumer trust and hinder adoption. Additionally, staffing shortages pose challenges: the U.K.'s 2024 Clinical Radiology workforce census reported a 30% shortage of clinical radiologists, projected to reach 40% by 2028.
Market Opportunities
Advancements in therapeutic ultrasound applications-including neuromodulation, wound healing, targeted drug delivery, and cancer treatment-are opening significant opportunities for market expansion. For example, Insightec's Exablate 4000 platform, approved by ANVISA in 2021, uses MR-guided focused ultrasound for non-invasive treatment of essential tremor and Parkinson's disease.
Partnerships also offer avenues for growth. A notable example is the 2025 partnership between Buck Baits LLC and Kuhl Beans Roasting Company, strengthening supply chain stability and showcasing increasing collaboration within the imaging ecosystem.
Market Trends
A major trend accelerating market growth is the integration of artificial intelligence into compact ultrasound systems. AI algorithms enhance image clarity, automate measurements, improve real-time interpretation, and reduce operator dependency. In March 2025, Philips launched its AI-enabled Compact Ultrasound 5500CV, highlighting industry momentum toward smarter, more efficient imaging solutions.
Manufacturers are also developing portable 3D and 4D imaging systems to expand diagnostic capabilities. Philips' 5000 Series, launched at RSNA 2022, delivers advanced 3D imaging for cardiovascular, OB/GYN, and point-of-care applications.
Segmental Insights
The built-in-console segment dominates due to increasing launch of console-based portable devices such as Mindray's Consona series in 2024. The touchscreen segment is expected to grow steadily due to rising demand for lightweight, modern, touch-operated systems.
The 3D imaging segment leads the imaging type category, followed by rapid growth in 4D imaging for real-time visualization.
Among applications, radiology accounted for the largest share in 2024, supported by AI-enabled device launches such as Wipro GE's Versana Premier R3 in March 2025. Hospitals & clinics remain the leading end-users, driven by rising admissions and increasing use of ultrasound for chronic disease diagnosis.
North America leads the market, while Europe shows steady growth supported by new product launches like Canon's Aplio Flex and Aplio Go systems in 2023. Asia Pacific is the fastest-growing region, driven by rising chronic disease prevalence and increasing focus on early diagnosis. Latin America and the Middle East & Africa are expanding due to strategic healthcare initiatives and growing access to diagnostics.
Conclusion
With the global market increasing from USD 2.65 billion in 2024 to USD 6.40 billion by 2032, compact ultrasound equipment is set for strong future growth. The industry's shift toward portability, AI integration, and preventive diagnostics will play a crucial role in shaping healthcare delivery worldwide.
Segmentation By Product Type
By Imaging Type
By Application
By End-user
By Region